The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers (Q37401496)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 August 2009
edit
Language Label Description Also known as
English
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
scientific article published on 25 August 2009

    Statements

    The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    O M Sinilnikova
    S Healey
    M Léoné
    kConFab
    M H Greene
    J T Loud
    F Lejbkowicz
    S Dishon
    S M Domchek
    A L Laborde
    M Durán
    F B L Hogervorst
    T A M van Os
    H J P Gille
    S Peock
    M Cook
    C Luccarini
    F Lalloo
    G Pichert
    R Davidson
    T Cole
    J Cook
    J Paterson
    C Brewer
    EMBRACE
    D J Hughes
    I Coupier
    F Coulet
    C Colas
    F Soubrier
    E Rouleau
    I Bièche
    R Lidereau
    L Demange
    C Nogues
    H T Lynch
    B Versmold
    C Sutter
    H Deissler
    D Schaefer
    U G Froster
    GC-HBOC
    K Aittomäki
    L McGuffog
    Consortium of Investigators of Modifiers of BRCA1/2
    25 August 2009
    101
    1456-1460

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit